1374041-49-2Relevant academic research and scientific papers
HCV NS3 PROTEASE INHIBITORS
-
Page/Page column 24, (2013/07/25)
The present invention is directed to compounds, compositions and methods for treating or preventing HCV viral infections in human patients or other animal hosts.
NOVEL SPECIFIC HCV NS3 PROTEASE INHIBITORS
-
Page/Page column 23, (2012/05/20)
The present invention is directed to compounds, compositions and methods for treating or preventing viral infections, in particular, HCV in human patients or other animal hosts.
